Invesco India Pharma and Healthcare Fund
Factual scheme page. Every figure below is as reported by the data source on the date shown, and is a record of the past — not a forecast and not a promise.
- Latest NAV: ₹9.7500 (as on 3 Nov 2026)
- Fund house: Invesco Mutual Fund
- Category: Equity Scheme - Sectoral/ Thematic
- Plan: Regular Plan
- Option: Growth
- AUM: ₹95 crore
- Expense ratio: 3.81%
- Benchmark: BSE Healthcare TRI
- Riskometer: Very High Risk
- Inception: 18 Aug 2026
- Exit load: Exit Load^:
For each purchase of units through Lumpsum / switch-in / Systematic Investment Plan
(SIP), Systematic Transfer Plan (STP) and IDCW Transfer Plan, exit load will be as
follows:
• if units are redeemed/switched out on or before 3 months from the date of allotment:
0.50%
• if units are redeemed/switched-out after 3 months: Nil
• Switch between the Plans under the Scheme: Nil
^Exit Load charged, if any, will be credited back to the scheme, net of Goods and Services
Tax
Returns as reported (CAGR)
Mutual fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not indicative of future returns. Aumsetu publishes scheme facts and does not rate, rank or recommend any scheme.
Fund Explorer · Screener · Compare schemes · All fund houses
